Cyclacel Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Cyclacel Pharmaceuticals Stock Summary

Cyclacel Pharmaceuticals competes with Eliem Therapeutics, Ikena Oncology, Ovid Therapeutics, Connect Biopharma, and Edgewise Therapeutics. Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey. Cyclacel Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Cyclacel Pharmaceuticals Key Financial Ratios

Cyclacel Pharmaceuticals Key Balance Sheet Accounts

Cyclacel Pharmaceuticals Key Income Statement Accounts

Cyclacel Pharmaceuticals Key Cash Accounts

Cyclacel Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cyclacel Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Cyclacel Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cyclacel Pharmaceuticals competition to find correlations between indicators driving Cyclacel Pharmaceuticals's intrinsic value. More Info.Cyclacel Pharmaceuticals is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At present, Cyclacel Pharmaceuticals' Return On Equity is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cyclacel Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Cyclacel Pharmaceuticals Systematic Risk

Today, most investors in Cyclacel Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cyclacel Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cyclacel Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Cyclacel Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cyclacel Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cyclacel Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Cyclacel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cyclacel Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.